Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-25 @ 4:14 AM
NCT ID:
NCT03262220
Eligibility Criteria:
Inclusion Criteria:
* Karnofsky performance status ≥ 70
* Presence of any kind of haematological malignancy in complete remission (CR1, CR2 ore CR3) at time of transplantation, with the exception of patients with myelodysplastic syndrome.
* Patients that are scheduled for a BMT either using stem cell derived from bone marrow or peripheral blood stem cells.
* Candidates to receive a 10 Gy TBI treatment.
* Ability to stay still and lying on the treatment couch for at least 45 minutes.
* Informed Consent as documented by signature.
Exclusion Criteria:
* Karnofsky performance status \<70 intended as a patient unable to work; able to live at home and care for most personal needs with varying amount of assistance needed.
* Concurrent treatment with other experimental drugs or other anti-cancer therapy.
* Participation in another clinical trial and any concurrent treatment with any investigational drug within 4 weeks prior to trial entry/randomisation.
* Inability to comply with study and follow-up procedures.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT03262220
Study Brief:
Protocol Section:
NCT03262220